Effects of rolapitant administered intravenously on the pharmacokinetics of a modified cooperstown cocktail (midazolam, omeprazole, warfarin, caffeine, and …

X Wang, ZY Zhang, S Arora, J Wang… - The Journal of …, 2018 - Wiley Online Library
Rolapitant is a selective, long‐acting neurokinin‐1 receptor antagonist, approved in the
United States and Europe for prevention of delayed chemotherapy‐induced nausea and …
被引用次数：8 相关文章

Effects of Rolapitant Administered Intravenously on the Pharmacokinetics of a Modified Cooperstown Cocktail (Midazolam, Omeprazole, Warfarin, Caffeine, and …

X Wang, ZY Zhang, S Arora, J Wang… - Journal of Clinical …, 2018 - search.ebscohost.com
Abstract: Rolapitant is a selective, long‐acting neurokinin‐1 receptor antagonist, approved
in the United States and Europe for prevention of delayed chemotherapy‐induced nausea …

Effects of Rolapitant Administered Intravenously on the Pharmacokinetics of a Modified Cooperstown Cocktail (Midazolam, Omeprazole, Warfarin, Caffeine, and …

X Wang, ZY Zhang, S Arora, J Wang… - Journal of clinical …, 2018 - pubmed.ncbi.nlm.nih.gov
Rolapitant is a selective, long-acting neurokinin-1 receptor antagonist, approved in the
United States and Europe for prevention of delayed chemotherapy-induced nausea and …

Effects of Rolapitant Administered Intravenously on the Pharmacokinetics of a Modified Cooperstown Cocktail (Midazolam, Omeprazole, Warfarin, Caffeine, and …

X Wang, ZY Zhang, S Arora, J Wang, S Lu… - Journal of Clinical …, 2018 - europepmc.org
Rolapitant is a selective, long-acting neurokinin-1 receptor antagonist, approved in the
United States and Europe for prevention of delayed chemotherapy-induced nausea and …